Large client base Antibody Solutions has served more than 500 clients including all of the top 10 global pharmaceutical companies, indicating a broad, high-potential market for expanding services with enterprise-level accounts.

Full service capabilities With end-to-end antibody discovery and characterization capabilities plus antibody engineering, conjugation, and analytical methods, there are multiple cross-sell opportunities to existing clients seeking one-stop CRO or expanded assay development.

Global collaboration Headquartered in Santa Clara and active worldwide engagement suggest readiness to support multinational biopharma programs, offering scalable project management and 24/7/365 tracking that can appeal to global teams.

Non-dilutive growth Current revenue range and modest funding position the company for incremental sales through expanded service packages, faster timelines, or priority access programs without requiring equity or large upfront investments.

Strategic partnerships Past collaborations with academic and industry partners and active participation in major industry events indicate opportunities to pursue co-development, licensing, or strategic research collaborations to extend product lines.